Schulz, David W.
Pfizer (United States)
2 papers on CoChat
Most cited papers
- Verified
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry
Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation
Cited by 930
- Verified
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology
Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation
Cited by 533
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free